The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile

被引:51
作者
Blackburn, Patricia [1 ,2 ,3 ]
Lemieux, Isabelle [1 ]
Almeras, Natalie [1 ]
Bergeron, Jean [4 ]
Cote, Melanie [1 ]
Tremblay, Angelo [5 ]
Lamarche, Benoit [3 ,6 ]
Despres, Jean-Pierre [1 ,5 ]
机构
[1] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Quebec Chicoutimi, Phys Act & Hlth Sci Program, Saguenay, PQ G7H 2B1, Canada
[3] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1V 0A6, Canada
[4] CHUL Res Ctr, Lipid Res Ctr, Quebec City, PQ G1V 4G2, Canada
[5] Univ Laval, Div Kinesiol, Dept Social & Prevent Med, Quebec City, PQ G1V 0A6, Canada
[6] Univ Laval, Inst Nutraceut & Funct Foods, Quebec City, PQ G1V 0A6, Canada
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2009年 / 58卷 / 08期
关键词
CORONARY-HEART-DISEASE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; PROVISIONAL REPORT; ABDOMINAL OBESITY; ENLARGED WAIST; DENSE LDL; B LEVELS; MORTALITY; ASSOCIATION;
D O I
10.1016/j.metabol.2009.03.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The hypertriglyceridemic waist phenotype, the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria, and the International Diabetes Federation (IDF) criteria have been proposed as screening tools to identify subjects with features of the metabolic syndrome and therefore at increased cardiometabolic risk. The aim of the present study was to compare the ability of these 3 clinical approaches to identify individuals at increased cardiometabolic risk as suggested by the presence of deteriorated markers Such as hyperinsulinemia, elevated apolipoprotein B levels, small low-density lipoprotein particles, high C-reactive protein concentrations. and low adiponectin levels. For that purpose, physical and cardiometabolic characteristics of a sample of 272 white men recruited for various metabolic investigations were studied. The hypertriglyceridemic waist phenotype was defined as having both it high waist circumference (>= 90 cm) and increased fasting triglyceride levels (>= 2.0 mmol/L), Having at least 3 of the 5 NCEP-ATP III criteria or waist circumference of at least 94 cm plus any 2 of the 4 additional IDF criteria was also used to identify, individuals at increased cardiometabolic risk. A large proportion of men with the hypertriglyceridemic waist phenotype also met the NCEP-ATP III (82.7%) or IDF (89.2%) criteria. Men with the hypertriglyceridemic waist phenotype were characterized by alterations in their lipoprotein-lipid profile that included small low-density lipoprotein particles, increased apolipoprotein B and insulin levels, as well as reduced adiponectin concentrations, which were similar individuals meeting the NCEP-ATP III or the IDF criteria. Moreover, the Framingham risk score of men meeting any of the 3 screening tools criteria was higher and was similar across the 3 approaches (4.2, 3.8, and 3.7, respectively), These results Suggest that hypertriglyceridemic waist may be as discriminant as the NCEP-ATP III or the IDF criteria and could be used as all initial screening approach to identify individuals with deteriorated cardiometabolic risk markers. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1123 / 1130
页数:8
相关论文
共 53 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[5]  
[Anonymous], 1991, Anthropometric Standardization Reference Manual
[6]  
Balkau B, 1999, DIABETIC MED, V16, P442
[7]   Postprandial hyperlipidemia:: another correlate of the "hypertriglyceridemic waist" phenotype in men [J].
Blackburn, P ;
Lamarche, B ;
Couillard, C ;
Pascot, A ;
Bergeron, N ;
Prud'homme, D ;
Tremblay, A ;
Bergeron, J ;
Lemieux, I ;
Després, JP .
ATHEROSCLEROSIS, 2003, 171 (02) :327-336
[8]   Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor [J].
Bos, G ;
Dekker, JM ;
Heine, R .
DIABETES CARE, 2004, 27 (01) :283-284
[9]   SUR UN DOSAGE RAPIDE DU CHOLESTEROL LIE AUX ALPHA-LIPOPROTEINES ET AUX BETA-LIPOPROTEINES DU SERUM [J].
BURSTEIN, M ;
SAMAILLE, J .
CLINICA CHIMICA ACTA, 1960, 5 (04) :609-609
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497